News | Radiation Therapy | May 15, 2025

As part of the investment, the company will relocate the manufacturing operations of Varian, a Siemens Healthineers company, from Mexico to California, to improve its ability to respond to the demand for its radiotherapy solutions and reduce the complexity of its global supply chain.

Siemens Healthineers to Invest $150 Million in New, Expanded U.S. Facilities

May 14, 2025 — Siemens Healthineers is investing $150 million in new projects to expand production, create jobs and better serve customers in the United States, its largest market globally.

The new investments come on top of the $900 million Siemens Healthineers spends on R&D in the U.S. annually and more than $1 billion invested through facilities expansion, acquisitions and strategic partnerships in the U.S. since 2019.

The latest investments include:

  • Bringing manufacturing back to the U.S.: relocation of manufacturing operations for Varian, a Siemens Healthineers company, from Baja, Mexico to Palo Alto, CA, adding approximately 50 new manufacturing jobs. The change will reduce the complexity of our global supply chain and improve our ability to respond to demand for Varian’s radiotherapy solutions.
  • Strengthening supply-chain resilience: opening mega supply depots in Dayton, NJ and Manteca, CA to increase availability of parts by nearly a third and offer unprecedented delivery flexibility to customers.
  • Helping healthcare providers digitize and transform care delivery: construction of a 60,000 square foot Siemens Healthineers Experience Center in Charlotte, NC. The center is part of The Pearl, Charlotte’s research and innovation district.

"North Carolina is home to some of the leading research and innovation firms in the nation,” said North Carolina Governor Josh Stein. “Siemens Healthineers’ $141 million investment in the Pearl in Charlotte is the latest in a long line of companies that see the value of our well-trained workforce thanks to advanced health education programs in our state.”

Added John Kowal, president and head of Siemens Healthineers in the Americas: “Our significant U.S. employee base and broad portfolio of innovations are making vital contributions to the American healthcare system. With these new investments we’re further demonstrating our long-term commitment and desire to grow along with the American economy.”


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Subscribe Now